4//SEC Filing
Lydon Nicholas 4
Accession 0001179110-20-009900
CIK 0001597264other
Filed
Sep 20, 8:00 PM ET
Accepted
Sep 21, 4:21 PM ET
Size
4.6 KB
Accession
0001179110-20-009900
Insider Transaction Report
Form 4
Lydon Nicholas
Director
Transactions
- Sale
Common Stock
2020-09-17$80.00/sh−500$40,000→ 47,240 total
Footnotes (1)
- [F1]Effected pursuant to a trading plan adopted on February 27, 2020 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
Documents
Issuer
Blueprint Medicines Corp
CIK 0001597264
Entity typeother
Related Parties
1- filerCIK 0001639935
Filing Metadata
- Form type
- 4
- Filed
- Sep 20, 8:00 PM ET
- Accepted
- Sep 21, 4:21 PM ET
- Size
- 4.6 KB